Minted: - / 5000

3742 Enclomifene
e396f43e60c40311254dc74752c18c6d678f157e106fa7801266639730295f15

Properties

Background

Brown
Bottle

Light green
Cap

Blue
Syringe

Light green
Bubbles
No
Drops
No
Label
-

Chemistry

Formula
C26H28ClNO
Carbon
26
Polarity
Neutral

Enclomifene (former tentative brand names Androxal and EnCyzix), or enclomiphene , is a nonsteroidal selective estrogen receptor modulator of the triphenylethylene group which was under development for the treatment of male hypogonadism and type 2 diabetes. By December 2016, it was in preregistration and was under review by the Food and Drug Administration in the United States and the European Medicines Agency in the European Union. In January 2018, the Committee for Medicinal Products for Human Use of the European Medicines Agency recommended refusal of marketing authorization for enclomifene for the treatment of secondary hypogonadism. In April 2021, development of enclomifene was discontinued for all indications.

From Wikipedia, the free encyclopedia. License: CC BY-SA.